Analysis of prognostic factors in diffuse large B-cell lymphoma associated with rheumatic diseases.

Vadim Romanovich GorodetskiyNatalya ProbatovaTatiana ObukhovaVladimir Vasilyev

Published in: Lupus science & medicine (2022)

Except for the more common non-GCB subtype, we did not identify any other prognostic factor that could influence the prognosis of patients with RD-associated DLBCL. We believe that short OS in our patients was predominantly associated with decreased tolerance to lymphoma treatment.

Keyphrases

prognostic factors
diffuse large b cell lymphoma
epstein barr virus
end stage renal disease
chronic kidney disease
african american
replacement therapy